These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 28342782)

  • 21. Favorable outcome after complete resection in elderly soft tissue sarcoma patients: Japanese Musculoskeletal Oncology Group study.
    Yoneda Y; Kunisada T; Naka N; Nishida Y; Kawai A; Morii T; Takeda K; Hasei J; Yamakawa Y; Ozaki T;
    Eur J Surg Oncol; 2014 Jan; 40(1):49-54. PubMed ID: 24075825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients.
    Zagars GK; Ballo MT; Pisters PW; Pollock RE; Patel SR; Benjamin RS; Evans HL
    Cancer; 2003 May; 97(10):2530-43. PubMed ID: 12733153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities.
    Pisters PW; Leung DH; Woodruff J; Shi W; Brennan MF
    J Clin Oncol; 1996 May; 14(5):1679-89. PubMed ID: 8622088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of disease relapse in primary extremity soft-tissue sarcoma.
    Smith HG; Memos N; Thomas JM; Smith MJ; Strauss DC; Hayes AJ
    Br J Surg; 2016 Oct; 103(11):1487-96. PubMed ID: 27503444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Individualised risk assessment for local recurrence and distant metastases in a retrospective transatlantic cohort of 687 patients with high-grade soft tissue sarcomas of the extremities: a multistate model.
    Willeumier JJ; Rueten-Budde AJ; Jeys LM; Laitinen M; Pollock R; Aston W; Dijkstra PD; Ferguson PC; Griffin AM; Wunder JS; Fiocco M; van de Sande MA
    BMJ Open; 2017 Feb; 7(2):e012930. PubMed ID: 28196946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soft tissue sarcoma of extremities: the prognostic significance of adequate surgical margins in primary operation and reoperation after recurrence.
    Liu CY; Yen CC; Chen WM; Chen TH; Chen PC; Wu HT; Shiau CY; Wu YC; Liu CL; Tzeng CH
    Ann Surg Oncol; 2010 Aug; 17(8):2102-11. PubMed ID: 20217247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer.
    Leitch EF; Chakrabarti M; Crozier JE; McKee RF; Anderson JH; Horgan PG; McMillan DC
    Br J Cancer; 2007 Nov; 97(9):1266-70. PubMed ID: 17923866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Should High-grade Extraosseous Osteosarcoma Be Treated With Multimodality Therapy Like Other Soft Tissue Sarcomas?
    Fan Z; Patel S; Lewis VO; Guadagnolo BA; Lin PP
    Clin Orthop Relat Res; 2015 Nov; 473(11):3604-11. PubMed ID: 26197952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study.
    Proctor MJ; Morrison DS; Talwar D; Balmer SM; Fletcher CD; O'Reilly DS; Foulis AK; Horgan PG; McMillan DC
    Eur J Cancer; 2011 Nov; 47(17):2633-41. PubMed ID: 21724383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colorectal Cancer, Systemic Inflammation, and Outcome: Staging the Tumor and Staging the Host.
    Park JH; Watt DG; Roxburgh CS; Horgan PG; McMillan DC
    Ann Surg; 2016 Feb; 263(2):326-36. PubMed ID: 25575264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the prognostic value of longitudinal measurements of systemic inflammation in patients undergoing curative resection of colorectal cancer.
    Guthrie GJ; Roxburgh CS; Farhan-Alanie OM; Horgan PG; McMillan DC
    Br J Cancer; 2013 Jul; 109(1):24-8. PubMed ID: 23799846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for local recurrence and metastasis in soft tissue sarcomas of the extremity.
    Sabolch A; Feng M; Griffith K; Rzasa C; Gadzala L; Feng F; Biermann JS; Chugh R; Ray M; Ben-Josef E
    Am J Clin Oncol; 2012 Apr; 35(2):151-7. PubMed ID: 21336091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical, surgical, and molecular prognostic factors for survival after spinal sarcoma resection.
    Sciubba DM; De la Garza Ramos R; Goodwin CR; Abu-Bonsrah N; Bydon A; Witham TF; Bettegowda C; Gokaslan ZL; Wolinsky JP
    Neurosurg Focus; 2016 Aug; 41(2):E9. PubMed ID: 27476851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone versus soft-tissue sarcomas in the elderly.
    Torigoe T; Terakado A; Suehara Y; Kurosawa H; Yazawa Y; Takagi T
    J Orthop Surg (Hong Kong); 2010 Apr; 18(1):58-62. PubMed ID: 20427836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulmonary metastasectomy for osteogenic and soft tissue sarcoma: who really benefits from surgical treatment?
    Mizuno T; Taniguchi T; Ishikawa Y; Kawaguchi K; Fukui T; Ishiguro F; Nakamura S; Yokoi K
    Eur J Cardiothorac Surg; 2013 Apr; 43(4):795-9. PubMed ID: 22833540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The elevated pre-operative plasma fibrinogen level is an independent negative prognostic factor for cancer-specific, disease-free and overall survival in soft-tissue sarcoma patients.
    Szkandera J; Pichler M; Liegl-Atzwanger B; Absenger G; Stotz M; Ploner F; Stojakovic T; Samonigg H; Eberhard K; Leithner A; Gerger A
    J Surg Oncol; 2014 Feb; 109(2):139-44. PubMed ID: 24122271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Management of soft tissue sarcomas in first isolated local recurrence: a retrospective study of 83 cases].
    Moureau-Zabotto L; Thomas L; Bui BN; Chevreau C; Stockle E; Martel P; Bonneviale P; Marques B; Coindre JM; Kantor G; Matsuda T; Delannes M
    Cancer Radiother; 2004 Oct; 8(5):279-87. PubMed ID: 15561593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective study of the role of inflammation in renal cancer.
    Qayyum T; McArdle PA; Lamb GW; Going JJ; Orange C; Seywright M; Horgan PG; Oades G; Aitchison MA; Edwards J
    Urol Int; 2012; 88(3):277-81. PubMed ID: 22377628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Superficial extremity soft tissue sarcoma: an analysis of prognostic factors.
    Brooks AD; Heslin MJ; Leung DH; Lewis JJ; Brennan MF
    Ann Surg Oncol; 1998; 5(1):41-7. PubMed ID: 9524707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Local recurrence is correlated with decreased overall survival in patients with intermediate high-grade localized primary soft tissue sarcoma of extremity and abdominothoracic wall.
    Zhao R; Yu X; Feng Y; Yang Z; Chen X; Wand J; Ma S; Zhang Z; Guo X
    Asia Pac J Clin Oncol; 2018 Apr; 14(2):e109-e115. PubMed ID: 29071781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.